M3 Wake Research Inc

1. Moderna TX, Inc. $14,867,826 670 payments
2. Pfizer Inc. $9,730,705 391 payments
3. Bavarian Nordic A/S $2,176,868 128 payments
4. Allergan Inc. $1,257,938 68 payments
5. Mylan Inc. $496,986 56 payments
6. Aclaris Therapeutics, Inc. $482,119 23 payments
7. GlaxoSmithKline, LLC. $432,844 87 payments
8. Novavax Inc $288,781 37 payments
9. Janssen Research & Development, LLC $274,963 41 payments
10. AbbVie, Inc. $224,560 55 payments

1. A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age $9,831,615 186 payments
2. A Phase 123 Placebocontrolled Randomized Observerblind Dosefinding Study to Evaluate the Safety Tolerability Immunogenicity and Efficacy of Sarscov2 Rna Vaccine Candidates Against Covid19 in Healthy Adults $5,988,593 89 payments
3. A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older $2,263,131 205 payments
4. ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 $1,825,739 52 payments
5. A Phase 3 Master Protocol to Evaluate Additional Doses of Bnt162b2 in Healthy Individuals Previously Vaccinated With Bnt162b2 $1,384,937 41 payments
6. A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age $1,164,913 66 payments
7. A Phase 3 Randomized Observerblinded Study to Evaluate the Safety Tolerability and Immunogenicity of A Combined Modified Rna Vaccine Candidate Against Covid19 and Influenza in Healthy Individuals $566,733 24 payments
8. A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis $503,787 36 payments
9. Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $496,986 56 payments
10. A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice A Week in Subjects With Common Warts $482,119 23 payments

1. Professional salary support $70,367 25 payments
2. Other $26,974 6 payments
3. Patient care $269 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.